Skip to main content

The British Society of Gastroenterology(BSG)

runs an annual scientific meeting at which many hundreds of original papers are presented to audiences approaching 2,600 professionals. It is also intimately involved in all aspects of training in British gastroenterology and original research in the field. Research is supported indirectly through the promotion of high standards and offering platforms for scientific presentation and publication, and directly through substantial financial contributions to the Society's affiliated charity, Guts UK. The BSG co-owns three journals. Gut is Europe's highest-ranked gastroenterology journal by citation-related impact factor and the Society's oldest title. Frontline Gastroenterology focuses on the clinical aspects of gastroenterology.


About

About The 2nd BSG International Gastroenterology Conference 2026 

The 2nd BSG International Gastroenterology Conference: From GI Inflammation to Cancer – Connecting the Dots will take place on 8–9 May 2026 in Dubai, organized by the British Society of Gastroenterology (BSG). Building on the success of the 2024 edition, this landmark meeting will bring together gastroenterologists, hepatologists, oncologists, surgeons, endocrinologists, radiologists, researchers, and industry leaders from around the world. The program is designed to explore the inflammation–cancer continuum, highlighting how chronic gastrointestinal and hepatobiliary diseases evolve into malignancy, and how innovative approaches can prevent or interrupt this process.

Vision And Scope

This joint conference aims to bridge the clinical and academic knowledge gap between gastroenterology and oncology by focusing on the inflammatory cancer continuum.Delegates will explore how chronic GI and hepatobiliary conditions evolve into malignancy and what interventions—medical, endoscopic, surgical, and pharmacologic can break that chain

Target Audience

Gastroenterologists

Hepatologists

Endocrinologists

Oncology nurses, GI trainees, researchers

Oncologists

GI surgeons

GI pathologists and radiologists

Industry partners (pharma, endoscopy devices)


Keyes

1- The Inflammation–Cancer Axis and early detection strategies

2-Endoscopic and surgical innovations in diagnosis and therapy

3- Hepatobiliary and pancreatic disease pathways

4- Obesity and GI cancer risk

Alongside plenary sessions and symposia, we are delighted to offer  hands-on training  modules in advanced endoscopy, EUS, EMR/ESD, GI bleeding control, and FibroScan,  designed to equip participants with practical skills directly applicable to clinical practice.


We greatly appreciate our esteemed faculty of speakers from the UK and UAE for the time, energy and thought that they have invested in supporting the program. We extend our sincere gratitude to all sponsors, partners, and organizers for their invaluable contributions in making this event possible.

Most of all, we thank you, the participants, for enriching these annual confer ences by your presence. I hope you will enjoy the content, renew old friend ships, make new friends, get new ideas, and above all, have a good time.

The aims of the meeting are

1- To deliver state-of-the-art updates on investigation, management, and new developments across gastroenterology, hepatology, and gastrointestinal oncology.
2- To provide high-quality CPD and hands-on educational opportunities for attendees.
3- To enable faculty and colleagues from diverse specialties to present, share, and debate their findings in an open, multidisciplinary forum.
4- To foster collaborative research and clinical partnerships between international experts and regional leaders.

Conference Highlights

The conference will feature:
1. Plenary sessions, symposia, and panel discussions led by global experts
2. Hands-on workshops and training modules in advanced diagnostic and therapeutic skills
3. Opportunities for multidisciplinary collaboration and networking